Stem cell therapy for multiple system atrophy
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a patient's own stem cells can help treat multiple system atrophy, a rare condition that affects movement and balance. The therapy may help slow or improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple system atrophy (MSA-P or MSA-C)
- You are between 35 and 65 years old
- You have not had stem cell therapy before
- You do not have other major brain or nervous system disorders
- Your heart, kidneys, and liver are functioning well
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests a new stem cell treatment for people with multiple system atrophy (MSA), a rare brain disorder that affects movement and automatic body functions. The treatment uses stem cells from healthy donors, which may help slow down the disease.
This trial tests a new cell therapy given directly into the brain to see if it is safe and can help with symptoms of multiple system atrophy (MSA), a condition that affects movement and balance. It may offer a new way to slow or improve symptoms for people with this disease.
This trial uses your own blood stem cells to reboot your immune system, which may help stop multiple sclerosis attacks and slow disability. It is for people with active MS that has not responded well to other treatments.
This phase 3 trial tests a new oral drug (MSA-01) for people with multiple system atrophy. It aims to see if the drug can slow disease progression and improve daily function.
This early-phase trial tests a new drug called ALT001 for people with multiple system atrophy (MSA). It aims to see if the drug is safe and may help slow the disease.
Hear when a new MSA - Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.